Pharma & Biotech ImmuPharma appoints Bachem to manufacture key ingredient for diabetes drug By Ian Lyall 25/06
Pharma & Biotech Bank sees structural strength in GLP-1 market as obesity drives demand By Ian Lyall 24/06
Medical technology & services Coiled Therapeutics appoints biotech veteran Craig Tooman to board By Ian Lyall 24/06
Pharma & Biotech ImmuPharma flags Murcia research into P140 as potential brain cancer treatment By Ian Lyall 24/06
Pharma & Biotech Cavendish backs CelLBxHealth turnaround with buy rating, 4p target By Ian Lyall 22/06
Pharma & Biotech Novo Nordisk's Wegovy pill headlines mask complicated competitive reality By Ian Lyall 22/06
Medical technology & services AbbVie to acquire Apogee Therapeutics in $10.9B deal By Emily Jarvie 22/06
Pharma & Biotech CelLBxHealth guides for 50% revenue growth as partnership pipeline swells By Ian Lyall 22/06
Pharma & Biotech Syncona's discount cited as opportunity, but investment bank reckons it might need a catalyst By Jamie Ashcroft 18/06
Pharma & Biotech Coiled Therapeutics recruits oncology heavyweights to advise on lead cancer drug By Ian Lyall 17/06
Pharma & Biotech Poolbeg's European patent win bolsters partnering case before summer trial data, says Cavendish By Ian Lyall 16/06
Pharma & Biotech BSF Enterprise says its talking to global sportswear brand and a tier-one auto manufacturer By Jamie Ashcroft 16/06
Pharma & Biotech Cizzle Biotechnology rises as US patent granted for lung cancer test By Oliver Haill 12/06
Pharma & Biotech Allergy Therapeutics to showcase pollen and food allergy progress By Jamie Ashcroft 12/06
Pharma & Biotech BSF Enterprise says 'T-Rex' auction sharpened interest in bio-leather By Proactive 12/06
Pharma & Biotech BSF Enterprise secures £1m as it advances commercial work for its tissue generation businesses By Jamie Ashcroft 11/06
